论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

桔梗白散治疗非小细胞肺癌小鼠的作用研究OA北大核心CSTPCD

Effects of Platycodon grandiflorum Bai powder in the treatment non-small cell lung cancer rats

中文摘要英文摘要

目的 观察中药复方桔梗白散对Lewis肺癌小鼠皮下移植瘤生长及组织中 B淋巴细胞瘤-2(Bcl-2)、Bcl-2相关X蛋白(Bax)、胱天蛋白酶(caspase)-3、caspase-9表达的影响.方法 建立Lewis肺癌移植瘤小鼠模型,将70只SPF级雄性C57BL/6小鼠随机分为空白组、模型组、低剂量实验组、中剂量实验组、高剂量实验组、对照组、联合组.空白组、模型组灌胃0.9%NaCl 0.2 mL;对照组给予等量0.9%NaCl灌胃的同时腹腔注射顺铂25 mg·kg-1;高、中、低剂量实验组分别给予193、96、48 mg·kg-1·d-1桔梗白散0.2 mL灌胃;联合组以96 mg·kg-1·d1桔梗白散0.2 mL灌胃,同时腹腔注射顺铂25 mg·kg-1,隔日1次.以流式细胞术检测小鼠骨髓髓源性抑制细胞(MDSCs),以免疫荧光法观察肿瘤细胞中Bcl-2、Bax、caspase-3、caspase-9的表达.结果 空白组、模型组、低剂量实验组、中剂量实验组、高剂量实验组、对照组、联合组小鼠骨髓中MDSCs 百分比分别为(32.50±2.76)%、(63.13±3.14)%、(48.43±2.23)%、(42.53±1.28)%、(32.93±3.56)%(51.30±4.25)%和(19.90±6.21)%;模型组、低剂量实验组、中剂量实验组、高剂量实验组、对照组、联合组Bax荧光强度分别为 10.42±0.68、12.40±1.23、15.14±0.65、22.95±1.76、27.18±1.62 和31.61±1.28,Bcl-2 荧光强度分别为 36.85±0.80、33.92±4.20、28.88±1.01、20.04±2.21、15.69±2.36 和 6.05±0.73,caspase-3 荧光强度分别为5.28±0.44、7.63±0.55、9.66±0.85、14.73±1.18、17.95±1.29 和22.92±1.95,caspase-9 荧光强度分别为 9.48±0.90、11.57±0.72、13.45±0.93、15.73±1.44、19.20±0.96 和 23.21±1.51.中、高剂量实验组的上述指标与模型组比较,在统计学上差异均有统计学意义(均P<0.05);联合组的上述指标与对照组相比,在统计学上差异均有统计学意义(均P<0.05).结论 桔梗白散能够通过上调Bax、caspase-3、caspase-9表达,下调Bcl-2表达,抑制MDSCs,促进肿瘤细胞凋亡,抑制肿瘤生长.

Objective To observe the effects of traditional Chinese medicine compound Platycodon grandiflorum Bai powder on the growth of subcutaneously implanted tumor and the expression of B-cell lymphoma-2(Bcl-2),Bcl-2 associated X protein(Bax),cysteinyl aspartate specific proteinase(caspase)-3 and caspase-9 in subcutaneously implanted tumor of Lewis lung cancer mice.Methods The model of transplanted tumor of Lewis lung cancer in mice was established.Seventy SPF male C57BL/6 mice were randomly divided into blank group,model group,low dose experimental group,medium dose experimental group,high dose experimental group,control group and combined group.Blank group and model group were given 0.9%NaCl 0.2 mL by gavage;control group was given 0.9%NaCl by gavage and 25 mg·kg-1cisplatin intraperitoneally;high,medium,low dose experimental groups were given 193,96,48 mg·kg-1·d-1 Platycodon grandiflorum Bai powder 0.2 mL by gavage,respectively;combined group was given 96 mg·kg-1·d-1 Platycodon grandiflorum Bai powder 0.2 mL by gavage,and 25 mg·kg-1 cisplatin intraperitoneally,once every other day.The myelogenous suppressor cells(MDSCs)of mouse bone marrow were detected by flow cytometry,and the expressions of Bel-2,Bax,caspase-3 and caspase-9 in tumor cells were detected by immunofluorescence.Results The percentage of MDSCs in bone marrow of mice in blank group,model group,low dose experimental,medium,high dose experimental group,control group and combination group were(32.50±2.76)%,(63.13±3.14)%,(48.43±2.23)%,(42.53±1.28)%,(32.93±3.56)%,(51.30±4.25)%and(19.90±6.21)%,respectively.The fluorescence intensities of Bax in model group,low dose experimental group,medium dose experimental group,high dose experimental group,control group and combination group were 10.42±0.68,12.40±1.23,15.14±0.65,22.95±1.76,27.18±1.62 and 31.61±1.28;Bel-2 were 36.85±0.80,33.92±4.20,28.88±1.01,20.04±2.21,15.69±2.36 and 6.05±0.73;caspase-3 were 5.28±0.44,7.63±0.55,9.66±0.85,14.73±1.18,17.95±1.29 and 22.92±1.95;caspase-9 were 9.48±0.90,11.57±0.72,13.45±0.93,15.73±1.44,19.20±0.96 and 23.21±1.51.There were significant differences between medium,high dose experimental groups and model group(all P<0.05),and there were significant differences between combined group and control group(all P<0.05).Conclusion Platycodon grandiflorum Bai powder can up-regulating the expression of Bax,caspase-3 and caspase-9,down-regulating the expression of Bel-2,inhibiting MDSCs,promoting tumor cell apoptosis and inhibiting tumor growth.

袁超;李金田;梁建庆;张毅;孔思琪;胡蓉;张悦;刘瑜

甘肃中医药大学中医临床学院,甘肃兰州 730000甘肃中医药大学基础医学院,甘肃兰州 730000

中医学

桔梗白散;顺铂;肺癌;凋亡;B淋巴细胞瘤-2/Bcl-2相关X蛋白;胱天蛋白酶-3

Platycodon grandiflorum Bai powder;cisplatin;lung cancer;apoptosis;B-cell lymphoma-2/Bcl-2 associated X protein;cysteinyl aspartate specific proteinase-3

《中国临床药理学杂志》 2024 (011)

1608-1612 / 5

国家自然科学基金资助项目(82160872);甘肃省教育厅"双一流"科研重点基金资助项目(GSSYLXM-05);甘肃省中医药研究中心开放课题基金资助项目(zyzx-2020-zx17);中医学一级学科"岐黄英才"导师专项基金资助项目(2022-13);甘肃中医药大学研究生创新创业基金资助项目

10.13699/j.cnki.1001-6821.2024.11.014

评论

下载量:0
点击量:0